Search Filters

Search Results

Found 2 results

510(k) Data Aggregation

    K Number
    K222179
    Date Cleared
    2023-03-28

    (249 days)

    Product Code
    Regulation Number
    892.2080
    Reference & Predicate Devices
    Why did this record match?
    Device Name :

    Annalise Enterprise CXR Triage Trauma

    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use

    Annalise Enterprise CXR Triage Trauma is a software workflow tool designed to aid the clinical assessment of adult chest X-ray cases with features suggestive of pleural effusion and pneumoperitoneum in the medical care environment.

    The device analyzes cases using an artificial intelligence algorithm to identify findings. It makes case-level output available to a PACS or RIS for worklist prioritization or triage.

    The device is intended to be used by trained clinicians who are qualified to interpret chest X-rays as part of their scope of practice.

    The device is not intended to direct attention to specific portions of an image or to anomalies other than pleural effusion and pneumoperitoneum.

    Its results are not intended to be used on a standalone basis for clinical decision making nor is it intended to rule out specific critical findings, or otherwise preclude clinical assessment of X-ray cases.

    Standalone performance evaluation of the device was performed on a dataset that included supine and erect positioning. Use of this device with prone positioning may result in differences in performance.

    Standalone performance evaluation of the device was performed on a dataset where most cases were of unilateral right sided and bilateral pneumoperitoneum. Use of this device for unilateral left sided pneumoperitoneum may result in differences in performance.

    Specificity may be reduced for pleural effusion in the presence of scarring and and/or pleural thickening.

    Device Description

    Annalise Enterprise CXR Triage Trauma is a software workflow tool which uses an artificial intelligence (AI) algorithm to identify suspected findings on chest X-ray (CXR) studies in the medical care environment. The findings identified by the device include pleural effusion and pneumoperitoneum.

    Radiological findings are identified by the device using an AI algorithm - a convolutional neural network trained using deep-learning techniques. Images used to train the algorithm were sourced from datasets across three continents, including a range of equipment manufacturers and models. The performance of the device's AI algorithm was validated in a standalone performance evaluation, in which the case-level output from the device was compared with a reference standard ('ground truth'). This was determined by two ground truthers, with a third truther used in the event of disagreement. All truthers were US board-certified radiologists.

    The device interfaces with image and order management systems (such as PACS/RIS) to obtain CXR studies for processing by the AI algorithm. Following processing, if any of the clinical findings of interest are identified in a CXR study, the device provides a notification to the image and order management system for prioritization of that study in the worklist. This enables users to review the studies containing features suggestive of these clinical findings earlier than in the standard clinical workflow. It is important to note that the device will never decrease a study's existing priority in the worklist. This ensures that worklist items will never have their priorities downgraded based on AI results.

    The device workflow is performed parallel to and in conjunction with the standard clinical workflow for interpretation of CXRs. The device is intended to aid in prioritization and triage of radiological medical images only.

    AI/ML Overview

    Here's a breakdown of the acceptance criteria and the study proving the device meets them, based on the provided text:

    Acceptance Criteria and Device Performance

    The document describes the performance of the Annalise Enterprise CXR Triage Trauma device in identifying pleural effusion and pneumoperitoneum. The acceptance criteria are implicitly demonstrated by the reported sensitivities and specificities at various operating points, which are presented as evidence of effective triage and substantial equivalence to the predicate device. While explicit "acceptance criteria" are not listed as pass/fail thresholds in the provided text, the performance metrics below are what the sponsor used to demonstrate the device met the requirements.

    Table of Reported Device Performance:

    FindingOperating pointSensitivity (95% CI)Specificity (95% CI)AUC (95% CI)
    Pleural effusion0.230296.0 (94.2,97.7)88.3 (85.3,91.1)0.980 (0.972-0.986)
    0.299093.8 (91.5,95.8)91.7 (89.3,94.1)
    0.435586.3 (83.0,89.4)95.6 (93.7,97.2)
    Pneumoperitoneum0.032290.1 (84.2,95.0)87.4 (82.4,92.3)0.969 (0.950-0.984)
    0.048486.1 (79.2,92.1)89.6 (85.2,94.0)
    0.226682.2 (75.2,89.1)96.2 (93.4, 98.9)

    Additionally, the device achieved an average triage turn-around time under 30.0 seconds. This implies an implicit acceptance criterion for speed, aiming for a rapid triage capability.

    Study Details

    1. Sample Sizes and Data Provenance

    • Test Set Sample Size: A total of 1269 CXR cases (582 positive, 687 negative) were used across two independent cohorts.
    • Data Provenance: The data was collected retrospectively and anonymized from four US hospital network sites. The cases were collected consecutively. The text also mentions that training data was sourced from "datasets across three continents."

    2. Number of Experts and Qualifications for Ground Truth

    • Number of Experts: For ground truth determination, a minimum of two experts were used, with a third expert used in case of disagreement.
    • Qualifications: All experts (ground truthers) were ABR-certified and protocol-trained radiologists. No specific years of experience are mentioned.

    3. Adjudication Method for the Test Set

    • The adjudication method for establishing ground truth was 2+1 consensus. This means two ground truthers blinded to each other's assessments first reviewed the cases, and a third ground truther was consulted to resolve any disagreements.

    4. Multi-Reader Multi-Case (MRMC) Comparative Effectiveness Study

    • No, a multi-reader multi-case (MRMC) comparative effectiveness study was not explicitly mentioned as being performed to show how human readers improve with AI vs. without AI assistance. The performance evaluation focused on the standalone performance of the AI algorithm for triage effectiveness.

    5. Standalone Performance (Algorithm Only)

    • Yes, a standalone performance evaluation was performed. The reported sensitivities, specificities, and AUC values in the table above demonstrate the algorithm's performance without integration into human workflow for diagnostic purposes, although it is evaluated for its "triage effectiveness."

    6. Type of Ground Truth Used

    • The ground truth was established by expert consensus of ABR-certified and protocol-trained radiologists.

    7. Sample Size for the Training Set

    • The specific sample size for the training set is not provided in the given text. It only states that the training dataset was "independent from the training dataset used in model development" relative to the test set and sourced from "datasets across three continents."

    8. How the Ground Truth for the Training Set was Established

    • The text does not explicitly detail how the ground truth for the training set was established. It only states that the AI algorithm was "trained using deep-learning techniques" and that the "Images used to train the algorithm were sourced from datasets across three continents." It can be inferred that a similar expert review process, likely by radiologists, would have been used to label the training data, but this is not explicitly stated in the provided excerpt.
    Ask a Question

    Ask a specific question about this device

    K Number
    K222268
    Date Cleared
    2023-03-28

    (243 days)

    Product Code
    Regulation Number
    892.2080
    Reference & Predicate Devices
    Why did this record match?
    Device Name :

    Annalise Enterprise CXR Triage Trauma

    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use

    Annalise Enterprise CXR Triage Trauma is a software workflow tool designed to aid the clinical assessment of adult chest X-ray cases with features suggestive of vertebral compression fracture in the medical care environment.

    The device analyzes cases using an artificial intelligence algorithm to identify findings. It makes case-level output available to a PACS or RIS for worklist prioritization or triage intended for clinicians in Bone Health and Fracture Liaison Service programs.

    The device is intended to be used by trained clinicians who are qualified to interpret chest X-rays as part of their scope of practice.

    The device is not intended to direct attention to specific portions of an image or to anomalies other than vertebral compression fracture.

    Its results are not intended to be used on a standalone basis for clinical decision making nor is it intended to rule out specific critical findings, or otherwise preclude clinical assessment of X-ray cases.

    Standalone performance evaluation of the device was performed on a dataset that included only erect positioning. Use of this device with supine positioning may result in differences in performance.

    Device Description

    Annalise Enterprise CXR Triage Trauma is a software workflow tool which uses an artificial intelligence (AI) algorithm to identify suspected findings on chest X-ray (CXR) studies in the medical care environment. The findings identified by the device include vertebral compression fractures.

    Radiological findings are identified by the device using an AI algorithm - a convolutional neural network trained using deep-learning techniques. Images used to train the algorithm were sourced from datasets across three continents, including a range of equipment manufacturers and models. The performance of the device's AI algorithm was validated in a standalone performance evaluation, in which the case-level output from the device was compared with a reference standard ('ground truth'). This was determined by two ground truthers, with a third truther used in the event of disagreement. All truthers were US board-certified radiologists.

    The device interfaces with image and order management systems (such as PACS/RIS) to obtain CXR studies for processing by the AI algorithm. Following processing, if the clinical finding of interest is identified in a CXR study, the device provides a notification to the image and order management system for prioritization of that study in the worklist. This enables users to review the studies containing features suggestive of these clinical findings earlier than in the standard clinical workflow. It is important to note that the device will never decrease a study's existing priority in the worklist. This ensures that worklist items will never have their priorities downgraded based on AI results.

    The device workflow is performed parallel to and in conjunction with the standard clinical workflow for interpretation of CXRs. The device is intended to aid in prioritization and triage of radiological medical images only.

    AI/ML Overview

    The provided text describes the Annalise Enterprise CXR Triage Trauma device, an AI-powered software tool designed to aid in the clinical assessment and triage of adult chest X-ray cases for vertebral compression fracture. Here's a breakdown of its acceptance criteria and the study proving its performance:

    Acceptance Criteria and Reported Device Performance

    FindingAcceptance Criteria (Metric)Reported Device Performance
    Vertebral compression fractureAUC (Area Under the Curve)0.954 (95% CI: 0.939-0.968)
    Vertebral compression fractureSensitivity (Se) at specific operating point89.3% (85.7-93.0%) at 0.3849 operating point
    Vertebral compression fractureSpecificity (Sp) at specific operating point89.0% (85.8-92.1%) at 0.3849 operating point
    Vertebral compression fractureSensitivity (Se) at specific operating point85.3% (80.9-89.3%) at 0.4834 operating point
    Vertebral compression fractureSpecificity (Sp) at specific operating point90.9% (87.7-94.0%) at 0.4834 operating point
    Triage Turn-Around TimeDemonstrates effective triage (implicitly compared to predicate device)Average 30.0 seconds

    Study Details

    1. Sample Size and Data Provenance:

      • Test Set Sample Size: 589 CXR cases (272 positive for vertebral compression fracture, 317 negative).
      • Data Provenance: Retrospective, anonymized study. Collected consecutively from four U.S. hospital network sites. The cases were collected from multiple data sources spanning a variety of geographical locations.
    2. Number of Experts and Qualifications for Ground Truth:

      • Number of Experts: At least two ABR-certified radiologists for initial annotation, with a third radiologist for disagreement resolution.
      • Qualifications: All truthers were U.S. board-certified radiologists who were protocol-trained.
    3. Adjudication Method for Test Set:

      • Consensus was determined by two ground truthers. A third ground truther was used in the event of disagreement. This is commonly referred to as a 2+1 adjudication method.
    4. Multi-Reader Multi-Case (MRMC) Comparative Effectiveness Study:

      • No MRMC comparative effectiveness study was explicitly mentioned or detailed in the provided text regarding how human readers improve with AI vs without AI assistance. The study described is primarily a standalone performance evaluation of the AI algorithm. The device's role is described as a "workflow tool" for worklist prioritization or triage, implying indirect assistance, rather than direct human-AI collaborative interpretation.
    5. Standalone Performance:

      • Yes, a standalone (algorithm only without human-in-the-loop) performance evaluation was done. The performance results (AUC, Sensitivity, Specificity) listed in the table above pertain to this standalone evaluation.
    6. Type of Ground Truth Used:

      • Expert consensus (blinded annotations by ABR-certified radiologists with adjudication).
    7. Training Set Sample Size:

      • The exact sample size for the training set is not explicitly stated. However, it is mentioned that "Images used to train the algorithm were sourced from datasets across three continents, including a range of equipment manufacturers and models." The test dataset was "newly acquired and independent from the training dataset used in model development."
    8. How Ground Truth for Training Set Was Established:

      • The document states that the AI algorithm was a "convolutional neural network trained using deep-learning techniques." While it mentions the source of the training data (datasets across three continents), it does not explicitly detail the method for establishing ground truth for the training set (e.g., expert review, pathology, or other means). The focus of the provided text is on the validation of the test set performance.
    Ask a Question

    Ask a specific question about this device

    Page 1 of 1